Alan Hamilton

2.9k total citations
74 papers, 2.2k citations indexed

About

Alan Hamilton is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Complementary and alternative medicine. According to data from OpenAlex, Alan Hamilton has authored 74 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Pulmonary and Respiratory Medicine, 32 papers in Physiology and 22 papers in Complementary and alternative medicine. Recurrent topics in Alan Hamilton's work include Chronic Obstructive Pulmonary Disease (COPD) Research (60 papers), Asthma and respiratory diseases (30 papers) and Respiratory Support and Mechanisms (22 papers). Alan Hamilton is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (60 papers), Asthma and respiratory diseases (30 papers) and Respiratory Support and Mechanisms (22 papers). Alan Hamilton collaborates with scholars based in Canada, Germany and United States. Alan Hamilton's co-authors include Denis E. O’Donnell, Katherine A. Webb, Lawrence Korducki, François Maltais, Steven Kesten, François Maltais, Eric Derom, Lars Grönke, Kay Tetzlaff and Kai Richter and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Molecular Biology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Alan Hamilton

72 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Hamilton Canada 25 1.8k 1.3k 301 216 154 74 2.2k
Matthew D. James Canada 13 433 0.2× 137 0.1× 95 0.3× 96 0.4× 179 1.2× 40 702
Glenn Crater United States 24 1.4k 0.8× 1.1k 0.9× 23 0.1× 73 0.3× 76 0.5× 80 1.7k
Paul S. Hees United States 18 143 0.1× 365 0.3× 238 0.8× 1.1k 5.1× 97 0.6× 30 1.9k
Robert Ross United States 25 118 0.1× 759 0.6× 77 0.3× 141 0.7× 2.0k 12.9× 40 3.2k
S.‐E. Lindell Sweden 19 317 0.2× 208 0.2× 21 0.1× 190 0.9× 225 1.5× 73 1.3k
Nathan J. Brown Australia 21 990 0.5× 840 0.7× 9 0.0× 19 0.1× 237 1.5× 79 1.6k
Yoshiko Mizuno Japan 20 145 0.1× 130 0.1× 40 0.1× 622 2.9× 286 1.9× 103 1.5k
Mario Del Donno Italy 16 1.4k 0.7× 1.2k 0.9× 17 0.1× 26 0.1× 146 0.9× 27 1.8k
Sérgio Stella Brazil 16 114 0.1× 166 0.1× 57 0.2× 50 0.2× 50 0.3× 31 795
Ellen F. Manzullo United States 17 630 0.3× 75 0.1× 36 0.1× 24 0.1× 116 0.8× 39 1.5k

Countries citing papers authored by Alan Hamilton

Since Specialization
Citations

This map shows the geographic impact of Alan Hamilton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Hamilton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Hamilton more than expected).

Fields of papers citing papers by Alan Hamilton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Hamilton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Hamilton. The network helps show where Alan Hamilton may publish in the future.

Co-authorship network of co-authors of Alan Hamilton

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Hamilton. A scholar is included among the top collaborators of Alan Hamilton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Hamilton. Alan Hamilton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harvey‐Dunstan, Theresa, Molly M Baldwin, Ruth Tal‐Singer, et al.. (2024). The Responsiveness of Exercise Tests in COPD. CHEST Journal. 167(1). 98–111. 2 indexed citations
2.
Casaburi, Richard, Debora Merrill, Thomas E. Dolmage, et al.. (2022). Endurance Time During Constant Work Rate Cycle Ergometry in COPD: Development of an Integrated Database From Interventional Studies. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 9(4). 520–537. 1 indexed citations
3.
Bourbeau, Jean, Maria Sedeno, Pei Zhi Li, et al.. (2021). Mechanisms associated with increased physical activity in patients undergoing self-management behaviour modification in the randomised PHYSACTO trial. ERJ Open Research. 7(1). 533–2020. 7 indexed citations
4.
Lewthwaite, Hayley, Magnus Ekström, Alan Hamilton, et al.. (2020). Predicting the rate of oxygen consumption during the 3-minute constant-rate stair stepping and shuttle tests in people with COPD. Journal of Thoracic Disease. 12(5). 2489–2498. 2 indexed citations
5.
Lavoie, Kim, Maria Sedeno, Alan Hamilton, et al.. (2019). Behavioural interventions targeting physical activity improve psychocognitive outcomes in COPD. ERJ Open Research. 5(4). 13–2019. 19 indexed citations
6.
Troosters, Thierry, François Maltais, Nancy Kline Leidy, et al.. (2018). Effect of Bronchodilation, Exercise Training, and Behavior Modification on Symptoms and Physical Activity in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 198(8). 1021–1032. 71 indexed citations
7.
Troosters, Thierry, Jean Bourbeau, François Maltais, et al.. (2016). Enhancing exercise tolerance and physical activity in COPD with combined pharmacological and non-pharmacological interventions: PHYSACTO randomised, placebo-controlled study design. BMJ Open. 6(4). e010106–e010106. 36 indexed citations
8.
9.
10.
Ichinose, Masakazu, et al.. (2015). Efficacy and safety of the long-acting β2-agonist olodaterol over 4 weeks in Japanese patients with chronic obstructive pulmonary disease. International Journal of COPD. 10. 1673–1673. 3 indexed citations
11.
Buhl, Roland, Eric Derom, Gary T. Ferguson, et al.. (2014). Once-daily tiotropium and olodaterol fixed-dose combination via the respimat improves outcomes vs mono-components in COPD in two 1-year studies. European Respiratory Journal. 44(Suppl 58). 1895–1895. 2 indexed citations
12.
Feldman, Gregory, Jonathan A. Bernstein, Alan Hamilton, et al.. (2014). The 24-h FEV1 time profile of olodaterol once daily via Respimat® and formoterol twice daily via Aerolizer® in patients with GOLD 2–4 COPD: results from two 6-week crossover studies. SpringerPlus. 3(1). 419–419. 34 indexed citations
13.
Koch, Andrea, Pierluigi Paggiaro, Alan Hamilton, et al.. (2013). Symptomatic benefit of olodaterol QD delivered via Respimat® vs placebo and formoterol BID in patients with COPD: Combined analysis from two 48-week studies. European Respiratory Journal. 42(Suppl 57). P763–P763. 7 indexed citations
14.
Maltais, François, et al.. (2013). Evaluation of the Effects of Olodaterol on Exercise Endurance in Patients With COPD: Results From Two 6-Week Studies. CHEST Journal. 144(4). 748A–748A. 8 indexed citations
15.
McGarvey, Lorcan, Andrea Koch, Alan Hamilton, et al.. (2013). 48-week administration of olodaterol QD via Respimat® vs placebo and formoterol BID in patients with COPD: Pooled safety analysis. European Respiratory Journal. 42(Suppl 57). P3633–P3633. 4 indexed citations
16.
17.
18.
Yount, Susan, Seung W. Choi, David Victorson, et al.. (2011). Brief, Valid Measures of Dyspnea and Related Functional Limitations in Chronic Obstructive Pulmonary Disease (COPD). Value in Health. 14(2). 307–315. 33 indexed citations
19.
O’Donnell, Denis E., François Maltais, Peter Frith, et al.. (2004). Perceived Locus of Symptom Limitation during Constant Work Rate Cycle Ergometry in COPD Patients Treated with Tiotropium. CHEST Journal. 126(4). 838S–838S. 1 indexed citations
20.
Carr, Daniel B., Kenneth J. Jones, Richard M. Bergland, et al.. (1985). Causal links between plasma and CSF endorphin levels in stress: Vector-ARMA analysis. Peptides. 6. 5–10. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthew D. James Breakdown of academic impact, for papers by Glenn Crater Breakdown of academic impact, for papers by Paul S. Hees Breakdown of academic impact, for papers by Robert Ross Breakdown of academic impact, for papers by S.‐E. Lindell Breakdown of academic impact, for papers by Nathan J. Brown Breakdown of academic impact, for papers by Yoshiko Mizuno Breakdown of academic impact, for papers by Mario Del Donno Breakdown of academic impact, for papers by Sérgio Stella Breakdown of academic impact, for papers by Ellen F. Manzullo
Rankless by CCL
2026